Literature DB >> 25059573

Prognostic relevance of Fédération Nationale des Centres de Lutte Contre le Cancer grade and MDM2 amplification levels in dedifferentiated liposarcoma: a study of 50 cases.

George Jour1, Ashley Gullet1, Mingdong Liu2, Benjamin L Hoch1.   

Abstract

Dedifferentiated liposarcoma represents a form of liposarcoma composed of a non-lipogenic sarcoma associated with well-differentiated liposarcoma. The prognostic significance of histological grading of the dedifferentiated component remains to be elucidated due to vague grading criteria employed in previous studies. Molecular markers of tumor behavior, including amplification levels of murine double minute-2 (MDM2) and cyclin-dependent kinase-4 (CDK4) genes, have been explored in a limited number of cases. Here we investigate whether 'Fédération Nationale des Centres de Lutte Contre le Cancer' (FNCLCC) grade and MDM2 gene amplification levels have prognostic value in dedifferentiated liposarcoma in terms of local recurrence and disease-specific survival. Fifty cases were retrieved, reviewed and FNCLCC grade was scored for the dedifferentiated component. Testing for MDM2 gene amplification was performed by fluorescence in situ hybridization. Amplification was categorized as high level (≥20 copies) and as low level (<20 copies). Follow-up data was obtained through chart review. Log-rank test and Cox proportional hazard models were used to determine the effect of grade and level of MDM2 amplification on outcomes. Our series includes 50 patients (male n=28, female n=22) with an average age of 63 years (range, 28-88) and a median follow-up of 28 months (range, 2-120). Tumors were graded as grade 1 (6%), grade 2 (58%), and grade 3 (36%). When adjusted for age, sex, site, tumor size, and margin status, grade 3 patients had a higher recurrence rate than grades 1 and 2 (HR=2.07, 95% CI: 1.24, 7.62; P=0.015). Patients with high-level MDM2 amplification had higher recurrence rate on univariate analysis (P=0.028), but not on multivariate analysis (HR=1.69, 95% CI: 0.73, 3.94; P=0.221). FNCLCC grade 3 dedifferentiation confers a worse prognosis in dedifferentiated liposarcoma in terms of local recurrence. MDM2 amplification level remains a useful diagnostic tool in dedifferentiated liposarcoma, but has no prognostic value in terms of local recurrence.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25059573     DOI: 10.1038/modpathol.2014.88

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  20 in total

1.  Cumulative effect of phosphorylation of pRB on regulation of E2F activity.

Authors:  V D Brown; R A Phillips; B L Gallie
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

2.  Characterization of centromere alterations in liposarcomas.

Authors:  N Sirvent; A Forus; W Lescaut; F Burel; S Benzaken; M Chazal; A Bourgeon; J R Vermeesch; O Myklebost; C Turc-Carel; N Ayraud; J M Coindre; F Pedeutour
Journal:  Genes Chromosomes Cancer       Date:  2000-10       Impact factor: 5.006

3.  Liposarcoma: a study of 55 cases with a reassessment of its classification.

Authors:  H L Evans
Journal:  Am J Surg Pathol       Date:  1979-12       Impact factor: 6.394

4.  Dedifferentiated liposarcoma: a clinicopathological analysis of 155 cases with a proposal for an expanded definition of dedifferentiation.

Authors:  W H Henricks; Y C Chu; J R Goldblum; S W Weiss
Journal:  Am J Surg Pathol       Date:  1997-03       Impact factor: 6.394

5.  High level of CDK4 amplification is a poor prognostic factor in well-differentiated and dedifferentiated liposarcoma.

Authors:  Seung Eun Lee; Yu Jin Kim; Mi Jeong Kwon; Dong Ill Choi; Jeeyun Lee; Junhun Cho; Sung Wook Seo; Sung Joo Kim; Young Kee Shin; Yoon-La Choi
Journal:  Histol Histopathol       Date:  2013-07-15       Impact factor: 2.303

6.  MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.

Authors:  Matthieu Bui Nguyen Binh; Xavier Sastre-Garau; Louis Guillou; Gonzague de Pinieux; Philippe Terrier; Réal Lagacé; Alain Aurias; Isabelle Hostein; Jean Michel Coindre
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

7.  Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomas: a study of 1240 patients from the French Federation of Cancer Centers Sarcoma Group.

Authors:  J M Coindre; P Terrier; L Guillou; V Le Doussal; F Collin; D Ranchère; X Sastre; M O Vilain; F Bonichon; B N'Guyen Bui
Journal:  Cancer       Date:  2001-05-15       Impact factor: 6.860

8.  Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma.

Authors:  Samuel Singer; Cristina R Antonescu; Elyn Riedel; Murray F Brennan
Journal:  Ann Surg       Date:  2003-09       Impact factor: 12.969

9.  HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.

Authors:  Antoine Italiano; Laurence Bianchini; Frédérique Keslair; Stéphanie Bonnafous; Nathalie Cardot-Leccia; Jean-Michel Coindre; Jean-Marc Dumollard; Paul Hofman; Agnès Leroux; Claire Mainguené; Isabelle Peyrottes; Dominique Ranchere-Vince; Philippe Terrier; Albert Tran; Philippe Gual; Florence Pedeutour
Journal:  Int J Cancer       Date:  2008-05-15       Impact factor: 7.396

Review 10.  The effects of surgery on tumor growth: a century of investigations.

Authors:  R Demicheli; M W Retsky; W J M Hrushesky; M Baum; I D Gukas
Journal:  Ann Oncol       Date:  2008-06-10       Impact factor: 32.976

View more
  6 in total

1.  Activation of the Akt-mTOR and MAPK pathways in dedifferentiated liposarcomas.

Authors:  Takeaki Ishii; Kenichi Kohashi; Kunio Iura; Akira Maekawa; Hirofumi Bekki; Yuichi Yamada; Hidetaka Yamamoto; Kazuki Nabeshima; Hiroyuki Kawashima; Yukihide Iwamoto; Yoshinao Oda
Journal:  Tumour Biol       Date:  2015-10-30

2.  Up-regulation of annexin A2 expression predicates advanced clinicopathological features and poor prognosis in hepatocellular carcinoma.

Authors:  Haijian Zhang; Min Yao; Wei Wu; Liwei Qiu; Wenli Sai; Junling Yang; Wenjie Zheng; Jianfei Huang; Dengfu Yao
Journal:  Tumour Biol       Date:  2015-06-26

Review 3.  Update on genomic and molecular landscapes of well-differentiated liposarcoma and dedifferentiated liposarcoma.

Authors:  Jun Lu; David Wood; Evan Ingley; Sulev Koks; Daniel Wong
Journal:  Mol Biol Rep       Date:  2021-04-24       Impact factor: 2.316

Review 4.  Update from the 5th Edition of the World Health Organization Classification of Head and Neck Tumors: Soft Tissue Tumors.

Authors:  Vickie Y Jo; Elizabeth G Demicco
Journal:  Head Neck Pathol       Date:  2022-03-21

5.  Dedifferentiated liposarcoma of the oral floor: A case study and literature review of 50 cases of head and neck neoplasm.

Authors:  Fumikazu Nimura; Toshiyuki Nakasone; Hirofumi Matsumoto; Tessho Maruyama; Akira Matayoshi; Nobuyuki Maruyama; Naoki Yoshimi; Akira Arasaki; Kazuhide Nishihara
Journal:  Oncol Lett       Date:  2018-03-15       Impact factor: 2.967

6.  Inhibition of histone deacetylase 2 reduces MDM2 expression and reduces tumor growth in dedifferentiated liposarcoma.

Authors:  Nathan D Seligson; Colin W Stets; Bryce W Demoret; Achal Awasthi; Nicholas Grosenbacher; Reena Shakya; John L Hays; James L Chen
Journal:  Oncotarget       Date:  2019-10-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.